Temozolomide Plus Irinotecan in Treating Patients With Recurrent Malignant Glioma
Conditions
- Brain and Central Nervous System Tumors
Interventions
- DRUG: irinotecan hydrochloride
- DRUG: temozolomide
Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Collaborators